<?xml version="1.0" encoding="UTF-8"?>
<p id="Par11">There are vast differences in the epidemiology and burden of hepatitis C across the globe that have significant implications for meeting the World Health Organization (WHO) 2030 hepatitis C elimination targets. A consequence is that responses to hepatitis C must be tailored to particular settings; major considerations include whether the epidemic is concentrated (e.g. among key populations such as people who inject drugs [PWID]) or generalised, the transmission mechanisms (e.g. syringe sharing versus iatrogenic transmission in healthcare settings), and the capacity of the health system to respond (e.g. infrastructure and human resources).</p>
